Cuprina Holdings is trading at $1.90, down 5.47%, amid broader market weakness; no confirmed direct catalyst was identified.

  • No fresh company-specific headline was reported for October 22; Schwab lists no company headlines for that date.
  • The Nasdaq fell 1.86% and the S&P 500 fell 1.00%. Bitcoin and Ethereum also fell more than 3% since the prior close, adding to risk-off sentiment; company coverage describes Cuprina as a biomedical company, not a crypto business.